Profarma Distribuidora de Produtos Farmacêuticos S.A (PFRM3) — Strategic Asset Allocation Index
Profarma Distribuidora de Produtos Farmacêuticos S.A (PFRM3) has a Strategic Asset Allocation Index of 45.9% as of September 2025. Strategic assets (PP&E of R$767.48 Million plus long-term investments of R$-) total R$767.48 Million, measured against net assets of R$1.67 Billion. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. See PFRM3 net asset quality index to measure how much of total assets are equity-financed.
SAAI
Strategic Assets
PP&E
Net Assets
Profarma Distribuidora de Produtos Farmacêuticos S.A Strategic Asset Allocation Index (2003–2024)
This chart shows how Profarma Distribuidora de Produtos Farmacêuticos S.A's Strategic Asset Allocation Index has evolved across 22 annual periods from 2003 to 2024. As of September 2025, the index stands at 45.9%, representing strategic assets of R$767.48 Million against net assets of R$1.67 Billion BRL. For live market cap and overall valuation, see market cap of Profarma Distribuidora de Produtos Farma.
Annual Strategic Asset Allocation Index for Profarma Distribuidora de Produtos Farmacêuticos S.A (2003–2024)
The table below presents the year-by-year Strategic Asset Allocation Index for Profarma Distribuidora de Produtos Farmacêuticos S.A from 2003 to 2024, covering 22 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. See PFRM3 total equity for net asset value and shareholders' equity analysis.
| Year | SAAI | Strategic Assets (BRL) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2024 | 42.5% | R$674.18 Million | R$674.18 Million | R$- | R$1.59 Billion | ▲ +7.7 pp |
| 2023 | 34.8% | R$535.59 Million | R$535.59 Million | R$- | R$1.54 Billion | ▲ +1.2 pp |
| 2022 | 33.6% | R$507.00 Million | R$507.00 Million | R$- | R$1.51 Billion | ▼ -1.6 pp |
| 2021 | 35.2% | R$519.02 Million | R$519.02 Million | R$- | R$1.48 Billion | ▲ +7.8 pp |
| 2020 | 27.4% | R$392.62 Million | R$392.62 Million | R$- | R$1.44 Billion | ▼ -6.8 pp |
| 2019 | 34.2% | R$343.19 Million | R$310.83 Million | R$32.36 Million | R$1.00 Billion | ▲ +18.6 pp |
| 2018 | 15.5% | R$158.67 Million | R$128.90 Million | R$29.77 Million | R$1.02 Billion | ▼ -13.0 pp |
| 2017 | 28.5% | R$212.70 Million | R$136.01 Million | R$76.69 Million | R$745.93 Million | ▲ +3.2 pp |
| 2016 | 25.3% | R$191.89 Million | R$112.07 Million | R$79.82 Million | R$758.96 Million | ▲ +5.3 pp |
| 2015 | 20.0% | R$133.37 Million | R$74.84 Million | R$58.52 Million | R$667.95 Million | ▲ +0.6 pp |
| 2014 | 19.4% | R$133.71 Million | R$52.91 Million | R$80.80 Million | R$688.85 Million | ▲ +1.5 pp |
| 2013 | 17.9% | R$102.47 Million | R$45.48 Million | R$56.98 Million | R$571.56 Million | ▲ +12.0 pp |
| 2012 | 5.9% | R$33.90 Million | R$33.90 Million | R$- | R$570.93 Million | ▲ +0.1 pp |
| 2011 | 5.8% | R$31.60 Million | R$31.60 Million | R$- | R$541.47 Million | ▲ +0.4 pp |
| 2010 | 5.4% | R$28.26 Million | R$28.26 Million | R$- | R$518.89 Million | ▼ -0.2 pp |
| 2009 | 5.6% | R$27.22 Million | R$27.22 Million | R$- | R$485.37 Million | ▲ +1.2 pp |
| 2008 | 4.4% | R$20.42 Million | R$20.42 Million | R$- | R$467.44 Million | ▲ +1.0 pp |
| 2007 | 3.4% | R$15.04 Million | R$15.04 Million | R$- | R$443.42 Million | ▲ +1.3 pp |
| 2006 | 2.1% | R$8.47 Million | R$8.47 Million | R$- | R$404.47 Million | ▼ -5.7 pp |
| 2005 | 7.8% | R$6.26 Million | R$6.26 Million | R$- | R$79.95 Million | ▼ -3.8 pp |
| 2004 | 11.7% | R$7.89 Million | R$7.89 Million | R$- | R$67.69 Million | ▼ -3.3 pp |
| 2003 | 14.9% | R$7.79 Million | R$7.79 Million | R$- | R$52.29 Million | — |